Clinical trial
Efficacy and Safety of Functional Neurogenesis Stimulation Therapy in Children With Autism Spectrum Disorder: A Multicenter, Randomized Controlled Trial
NCT07276555 is registered in ClinicalTrials.gov with Neurocytonix, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Functional Neurogenesis Stimulation Therapy in Children With Autism Spectrum Disorder: A Multicenter, Randomized Controlled Trial
- Lead sponsor
- Neurocytonix, Inc.
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- February 1, 2026
- Completion date
- May 29, 2029
- Enrollment
- 256 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.